INOMAX (nitric oxide) for inhalation

INOMAX® is nitric oxide for inhalation. INOMAX is a selective pulmonary vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.Refer to full Product Information.

The Therapeutic Goods Administration (TGA) specifies that INOMAX must be delivered through an approved nitric oxide delivery system meeting specific quality and safety criteria. For full details refer to INOMAX Product Information.

References

  1. INOmax® Australian Approved Product Information